When.com Web Search

  1. Ads

    related to: ayurvedic medicine for appetite increase muscle loss in older dogs treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Capromorelin - Wikipedia

    en.wikipedia.org/wiki/Capromorelin

    Capromorelin, sold under the brand names Entyce and Elura, is a medication used for the management of weight loss in cats and dogs. [5] [6] Capromorelin is a ghrelin receptor agonist known to increase appetite and weight gain. [2] Capromorelin was developed by Pfizer. [7] [8] Capromorelin was approved for veterinary use in the United States in ...

  3. Vet-Approved Home Treatment for Senior Dogs with Arthritis - AOL

    www.aol.com/vet-approved-home-treatment-senior...

    Related: Dog Arthritis Symptoms and Home Pain Remedies There are several things you can do at home to help an older dog with arthritis, including changing her diet. Photo by manfredxy, Canva

  4. Appetite stimulant - Wikipedia

    en.wikipedia.org/wiki/Appetite_stimulant

    An orexigenic, or appetite stimulant, is a drug, hormone, or compound that increases appetite and may induce hyperphagia. This can be a medication or a naturally occurring neuropeptide hormone, such as ghrelin , orexin or neuropeptide Y , [ 1 ] [ 2 ] which increases hunger and therefore enhances food consumption .

  5. Sibutramine - Wikipedia

    en.wikipedia.org/wiki/Sibutramine

    Sibutramine should not be taken within two weeks of stopping or starting an MAOI. Taking both sibutramine and certain medications used in the treatment of migraines—such as ergolines and triptans—as well as opioids, may also increase the risk for serotonin syndrome, as may the use of more than one serotonin reuptake inhibitor at the same time.

  6. Arthritis, back problems common with older dogs. Here are ...

    www.aol.com/news/arthritis-back-problems-common...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    The United States Food and Drug Administration and the European Medicines Agency have approved weight loss medications for adults with either a body-mass index (BMI) of at least 30, or a body-mass index of at least 27 with at least one weight-related comorbidity. This patient population is considered to have sufficiently high baseline health ...